Table: OncoTherapy Science -6-MTH group results
Nov 4 (Reuters)-
OncoTherapy Science Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2016 Sep 30, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 34 mln 208 mln
(-83.5 pct) (-40.8 pct)
Operating loss 1.52 loss 1.47
Recurring loss 1.50 loss 1.47
Net loss 1.50 loss 1.33
EPS loss 10.18 yen loss 9.08 yen
Ann Div NIL NIL
-Q2 div
-Q4 div NIL NIL
NOTE - OncoTherapy Science Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T
((Tokyo Headline News Desk +813 6441 1812))